DNA integrity in plasma and serum of patients with malignant and benign diseases.
Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare cell-free DNA concentrations and integrity indices between serum and plasma and between specimens from cancer patients and patients with benign diseases.
Summary of Findings
DNA concentrations measured by real time qPCR were higher among serum specimens than plasma specimens, regardless of diagnosis, and no correlation was seen between DNA concentrations or DNA integrity indices in serum and plasma. There were no significant differences between DNA concentrations in plasma from cancer patients and those with benign disease or between DNA concentrations in serum from cancer patients and those with benign disease. Without taking into account the specimen type, the median DNA integrity indices were also not significantly different between patient groups. The authors state that for serum and plasma, neither DNA concentration nor DNA integrity index was correlated with tumor characteristics such as size, stage, lymph node status, or the presence of metastasis.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
NeoplasticBenignNeoplasticCarcinomaPlatforms
DNAReal-time qPCRDNAPCRDNAElectrophoresisPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Benign diseaseCancerBiospecimen Aliquots and Components Blood and blood products PlasmaSerum